Log In
BCIQ
Print this Print this
 

Anascorp (Alacramyn)

  Manage Alerts
Collapse Summary General Information
Company Instituto Bioclon S.A. de C.V.
DescriptionFab fragments derived from the plasma of horses immunized with scorpion venom
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentMarketed
Standard IndicationPoisoning
Indication DetailsTreat scorpion envenomation; Treat scorpion stings by Centruroides scorpions
Regulatory Designation U.S. - Orphan Drug (Treat scorpion envenomation)
PartnerRare Disease Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today